Location: Animal Genomics and Improvement Laboratory
Title: International evaluations for clinical mastitis in Brown SwissAuthor
MOTA, RODRIGO - Council On Dairy Cattle Breeding | |
PARKER GADDIS, KRISTEN - Council On Dairy Cattle Breeding | |
Vanraden, Paul | |
MCWHORTER, TAYLOR - Council On Dairy Cattle Breeding | |
NICOLAZZI, EZEQUIEL - Council On Dairy Cattle Breeding |
Submitted to: Interbull Annual Meeting Proceedings
Publication Type: Proceedings Publication Acceptance Date: 9/18/2023 Publication Date: 12/13/2023 Citation: Mota, R.R., Parker Gaddis, K.L., Van Raden, P.M., Mcwhorter, T.M., Nicolazzi, E. 2023. International evaluations for clinical mastitis in Brown Swiss. Interbull Bulletin. 59:182-186. Interpretive Summary: Technical Abstract: The SNP training for clinical mastitis (STCM) trait was introduced by the Interbull Centre in April 2021. Previously, the mastitis trait within the udder trait group allowed for a wide range of trait definitions: direct clinical mastitis, somatic cell score, or a combination of clinical/subclinical mastitis. Since the introduction of STCM, the Council on Dairy Cattle Breeding (CDCB) has participated with data for Holsteins and Jerseys, aiming to enhance the domestic SNP reference population with foreign evaluations. As expected, for Holsteins and Jerseys the inclusion of Multiple Across Country Evaluation (MACE) evaluations had a minor impact on the US evaluation due to the dominance of US animals in the reference population. In the August 2022 evaluation, Brown Swiss (BSW) animals began receiving domestic health evaluations in the US, which were also incorporated into the Net Merit Index. During the January 2023 test run, the Brown Swiss STCM successfully completed Trend Methods I and III validation at Interbull. Starting from the April 2023 evaluation, BSW foreign evaluations were included in the United States of America (US) clinical mastitis evaluations. The initial expectation was that the impact of this inclusion would be limited, as only two other foreign countries (France and Switzerland) contribute to the CDCB clinical mastitis evaluation. However, the observed impact on the evaluations was noticeable. Correlations between the current, April 2023, and the previous, December 2022, triannual genomic evaluations were as low as 0.73 for reference animals and 0.56 for young animals. Along with the significant variation in Genomic Estimated Breeding Values (GEBV), the mean genomic reliabilities (GREL) for young animals increased from 24% in December to 30% in April. These results can be explained by two main factors: i) the contribution of foreign bulls from France and Switzerland in the SNP reference population for US Brown Swiss made the inclusion of MACE evaluations more relevant; ii) a large number of US Brown Swiss clinical mastitis records became available prior to the April 2023 evaluation and were added to the national cooperator database. Large changes in GEBV and GREL resulting from the initial inclusion of foreign data are not expected in subsequent evaluations unless more countries participate. |